RBC Capital analyst Shagun Singh upgraded Stryker to Outperform from Sector Perform with a price target of $284, up from $240. For 2023, The analyst favors medical supply and device stocks with exposure to procedures less likely to be deferred, new product cycles and the ability to win market share. Singh upgraded Stryker on the company’s strong medical and surgical equipment order book, "more meaningful" realization of its reconstructive backlog and easing macro pressures.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYK:
- Stryker price target raised to $265 from $257 at Barclays
- Stryker price target raised to $265, added to ‘TAP Outperform’ list at Evercore
- Hedge Funds Are Pouring Money into Stryker (NYSE:SYK) Stock
- Stryker to host conference call on January 31, 2023
- Stryker price target raised to $268 from $232 at BTIG
